Samantha McLemore's portfolio

Patient Capital Management · SEC CIK 1854794

Contrarian value with a long time horizon.

Q2 2026
Latest 13F
$3.01B
Filed US book
39
Positions
~890 days
Snapshot half-life

This filing is 93 days old. Patient Capital Management keeps roughly 93% of its positions in a typical quarter, so about 93% of this book is likely still intact today.

How half-life is computed

Snapshot half-life is the number of days after the period end at which half of this specific fund's reported book is expected to have changed, measured from its own past filings. It is a decay estimate, not knowledge of current positions.

Largest holdings, as filed

Top 10 of 39 positions. Weights are against the whole filed book. 13F filings cover US-listed holdings only.

CompanyTickerValue% of bookFreshness
ROYALTY PHARMA PLC$201.79M6.7%n/a
CITIGROUP INCC$196.43M6.5%
ALPHABET INCGOOGL$187.89M6.2%
UNITEDHEALTH GROUP INCUNH$181.95M6.0%
AMAZON COM INCAMZN$162.32M5.4%
NVIDIA CORPORATIONNVDA$141.98M4.7%
CVS HEALTH CORPCVS$127.81M4.3%
NORWEGIAN CRUISE LINE HLDGS$127.29M4.2%n/a
QXO INCQXO$123.32M4.1%
ENERGY TRANSFER L PET$116.26M3.9%

Freshness: how likely each position is still held today, from this fund's own turnover history, each position's tenure and the filing's age. Hover a bar for the numbers. Method.

What changed last quarter

Between Q1 2026 and Q2 2026, the largest add was AMZN (shares up 4%), now $162.32M; the largest trim was CVS (shares down 9%); IBIT no longer appears among the previous quarter's largest positions. All of it computed from the two filings, nothing inferred.

Biggest buys, Q2 2026

  • AMZN add +4%$162.32M
  • QXO add +5%$123.32M
  • PGEN add +7%$108.51M
  • CHYM add +42%$83.61M
  • ADBE add +22%$74.04M
  • GPN new$68.37M

Exited since Q1 2026

Exit scan covers the previous quarter's 40 largest positions, a stated bound, because reading a mega fund's entire book per page render is not honest engineering.

Common questions

What are Samantha McLemore's biggest holdings?

As of the Q2 2026 13F, the largest reported positions at Patient Capital Management are ROYALTY PHARMA PLC (6.7% of the book), C (6.5% of the book), GOOGL (6.2% of the book).

How big is Patient Capital Management's portfolio?

The latest 13F reports $3.01B across 39 US-listed positions. 13F filings cover US-listed holdings only, so non-US positions and shorts are not included.

Does Samantha McLemore still hold these positions?

Unknown for certain: a 13F may be filed up to 45 days after quarter end. Based on Patient Capital Management's own filing history, the fund keeps roughly 93% of positions in a typical quarter, so at 93 days since the period end roughly 93% of this book is likely intact. The snapshot half-life for this fund is about 890 days.

What did Samantha McLemore buy and sell last quarter?

Between Q1 2026 and Q2 2026, the largest add was AMZN (shares up 4%), now $162.32M; the largest trim was CVS (shares down 9%); IBIT no longer appears among the previous quarter's largest positions. All of it computed from the two filings, nothing inferred.

Funds with overlapping books

Every 13F we hold, quarter by quarter

Each filing has its own page: the whole book as filed that quarter and what changed from the filing before.

Inside the app: the full book for Patient Capital Management, quarter on quarter buys and sells, consensus across 140+ funds and copy-to-watchlist.

Source: SEC EDGAR 13F filings. Values are as filed and cover US-listed positions only. A 13F may be filed up to 45 days after the quarter ends, so positions can change before the filing is even public; the freshness figures above quantify that lag instead of hiding it. Educational information, not financial advice.